Duolin Inhaler 20/50mcg (India)
Duolin Inhaler 20/50mcg (India)
$37.99
Earn 2 points upon purchasing this product.
200 Doses
Requires Prescription
SKU: 89622 Categories: Asthma Medications COPD, Combivent Respimat Inhaler, Generic, India, Prescription DrugsUses of Duolin Inhaler
Duolin Inhaler is a prescription medicine used to treat chronic obstructive pulmonary disorder (COPD), a type of lung disorder that blocks airflow to the lungs). It works by relaxing the muscles of the air passages and enabling easier breathing. It diminishes symptoms, such as shortness of breath, wheezing, and coughing. Duolin Inhaler is a combination of Levosalbutamol 50 mcg and Ipratropium 20 mcg.
Duolin Inhaler Precautions and Warnings
Do not use Duolin Inhaler if you are allergic to it, particularly to its active ingredients Levosalbutamol 50 mcg and Ipratropium 20 mcg. To ensure that Duolin Inhaler is safe to consume, tell your healthcare professional if you have a history of the following conditions:
- Kidney disease
- Liver problems
- Cardiovascular disease
- Alcohol addiction
If you are pregnant or breastfeeding, ask your healthcare professional if it’s safe to use this medication. Note that some medicines can potentially harm your baby. Seek medical advice.
Duolin Inhaler Direction of Use
- Shake the inhaler first.
- Seal the mouthpiece inside the mouth and keep your head straight.
- Take a breath and exhale fully.
- Press the inhaler to release the medication.
- Breathe in and hold your breath for a few seconds.
- Repeat the process until you reach the prescribed dose.
- Rinse your mouth after using.
Duolin Inhaler Side Effects
Common side effects:
- Dry mouth
- Cough
- Headache
- Palpitation
- Muscle cramps
Only logged in customers who have purchased this product may leave a review.
Cart
Product Search
Product Categories
Top Rated Products
-
Aripiprazole 5mg
$126.97
-
Altace 10mg
$99.40
-
Mesalamine 400mg (Novo-5-ASA)
$67.42
-
Celecoxib 100mg
$32.99
-
S Citadep 50mg (India)
$34.99
-
Creon 10
$84.37
Reviews
There are no reviews yet.